From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives.  They have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations.  Their team of over 80 distinguished scientific, medical, investment and other professionals manages over $13 billion across public and private company investments worldwide.

Investment Management

OrbiMed

OrbiMed's headquarters in New York, NY, United States

Managing Partners

Carl L. Gordon

Sven H. Borho

David Wang

Matthew S. Rizzo

Steven D. Wang

Mona Ashiya

Erez Chimovits

Peter Thompson

David Bonita

C. Scotland Stevens

Girish Bakhru

Trevor M. Polischuk

Rishi Gupta

Geoffrey C. Hsu

Partners

People (8)